Testing effectiveness (Phase 2)Study completedNCT02864849
What this trial is testing
Total Neoadjuvant Induction and Consolidation CapeOX Plus IMRT With Capecitabine for MRI Defined High-risk Rectal Cancer
Who this might be right for
Rectal Cancer
Peking University Cancer Hospital & Institute 81